Quick Takeaways
- Cheryl Cohen has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $33,301.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Cheryl Cohen
- Location
- Hampton, NJ
- Summary
- The estimated net worth of Cheryl Cohen is at least $33,301 dollars as of 20 Jun 2025. Cheryl Cohen is the Director of Aerpio Pharmaceuticals, Inc. and owns shares of Whitehawk Therapeutics, Inc. (WHWK) stock worth about $33.3K.
- Signature
- /s/ Jason Liljestrom, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Cheryl Cohen and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Aerpio Pharmaceuticals, Inc. ($33,301).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Cheryl Cohen
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| WHWK | Aerpio Pharmaceuticals, Inc. | Director | $33,301 | 30 Jun 2021 | ||
| CLDX | Celldex Therapeutics, Inc. | Director | 05 Jun 2025 | |||
| IBRX | ImmunityBio, Inc. | Director | 18 Jun 2025 | |||
| LITS | MEI Pharma, Inc. | Director | 05 Jul 2022 |
Insider Transactions Reported by Cheryl Cohen:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.